Targeting Systemic Sclerosis from Pathogenic Mechanisms to Clinical Manifestations: Why IL-6?

Systemic sclerosis (SS) is a chronic autoimmune disorder, which has both cutaneous and systemic clinical manifestations. The disease pathogenesis includes a triad of manifestations, such as vasculopathy, autoimmunity, and fibrosis. Interleukin-6 (IL-6) has a special role in SS development, both in v...

Descripción completa

Detalles Bibliográficos
Autores principales: Cardoneanu, Anca, Burlui, Alexandra Maria, Macovei, Luana Andreea, Bratoiu, Ioana, Richter, Patricia, Rezus, Elena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869570/
https://www.ncbi.nlm.nih.gov/pubmed/35203527
http://dx.doi.org/10.3390/biomedicines10020318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869570/
https://www.ncbi.nlm.nih.gov/pubmed/35203527
http://dx.doi.org/10.3390/biomedicines10020318

Ejemplares similares